Advanced glycation end products (AGE) and diabetes: cause, effect, or both?
Study Goal
The researchers aimed to explore the relationship between exogenous advanced glycation end products (AGEs), chronic inflammation, insulin resistance (IR), and type 2 diabetes (T2D), and evaluate dietary AGE restriction as a nonpharmacologic intervention.
Results Summary
The study found that excessive consumption of AGEs contributes to chronic inflammation, IR, and T2D, and that dietary AGE restriction effectively lowers AGE levels, restores innate defenses, and improves IR.
Population
Not specified (general discussion, likely referencing broader populations with IR or T2D).
Effective Dosage
Not specified.
Duration
Not specified.
Interactions
None mentioned.
| Intervention | Direction | Endpoint | Population | Dosage | Impact | Claim # |
|---|---|---|---|---|---|---|
over-nutrition and obesity | increase | insulin resistance | - | - | associated with | #1 |
chronically elevated oxidant stress and chronic inflammation | increase | insulin resistance | - | - | results from | #2 |
excessive consumption of advanced glycation end products with the standard western diet | increase | inflammation | - | - | is a major cause for | #3 |
advanced glycation end products | increase | islet β-cell injury, peripheral insulin resistance and diabetes | - | - | are increasingly seen as a potential risk for | #4 |
chronic exogenous oxidant AGE pressure | decrease | innate defense mechanisms | - | - | depletes | #5 |
depletion of innate defense mechanisms | increase | inflammation, insulin resistance, type 2 diabetes and its complications | - | - | raises susceptibility to | #6 |
dietary AGE restriction | decrease | AGEs | - | - | effectively lowers | #7 |
dietary AGE restriction | increase | innate defenses | - | - | restores | #8 |
dietary AGE restriction | decrease | insulin resistance | - | - | improves | #9 |
Despite new and effective drug therapies, insulin resistance (IR), type 2 diabetes mellitus (T2D) and its complications remain major medical challenges. It is accepted that IR, often associated with over-nutrition and obesity, results from chronically elevated oxidant stress (OS) and chronic inflammation. Less acknowledged is that a major cause for this inflammation is excessive consumption of advanced glycation end products (AGEs) with the standard western diet. AGEs, which were largely thought as oxidative derivatives resulting from diabetic hyperglycemia, are increasingly seen as a potential risk for islet β-cell injury, peripheral IR and diabetes. Here we discuss the relationships between exogenous AGEs, chronic inflammation, IR, and T2D. We propose that under chronic exogenous oxidant AGE pressure the depletion of innate defense mechanisms is an important factor, which raises susceptibility to inflammation, IR, T2D and its complications. Finally we review evidence on dietary AGE restriction as a nonpharmacologic intervention, which effectively lowers AGEs, restores innate defenses and improves IR, thus, offering new perspectives on diabetes etiology and therapy.